PREVALENCE OF DONOR-SPECIFIC ANTI-HLA ANTIBODIES DURING EPISODES OF RENAL ALLOGRAFT REJECTION1

Abstract

Although the presence of donor-specific HLA antibodies presented a significant risk for acute or chronic rejection, 77% of all acute and chronic rejections occurred in patients without detectable HLA antibodies.